BAMCO Inc
MXCT icon

BAMCO Inc’s MaxCyte MXCT Stock Holding History

BAMCO Inc’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,987,904
Closed -$9.84M – 354
2023
Q1 		$9.84M Sell
1,987,904
-195,078
-9% -$961K 0.03% 232
2022
Q4 		$11.9M Sell
2,182,982
-84,967
-4% -$521K 0.04% 218
2022
Q3 		$14.7M Sell
2,267,949
-123,209
-5% -$687K 0.05% 217
2022
Q2 		$11.3M Sell
2,391,158
-2,207,511
-48% -$10.9M 0.04% 243
2022
Q1 		$32.1M Sell
4,598,669
-466,502
-9% -$3.18M 0.08% 185
2021
Q4 		$51.6M Buy
5,065,171
+3,521,537
+228% +$37.8M 0.11% 161
2021
Q3 		$18.8M Buy
+1,543,634
New +$23.3M 0.04% 261

Other funds holding MXCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

BAMCO Inc's MXCT Position: Q2 2023 in Review

BAMCO Inc sold out of MaxCyte (MXCT) in Q2 2023, closing a stake of 1,987,904 shares — an estimated $9.84M sold.

BAMCO Inc first reported a position in MXCT in Q3 2021 and held it in 7 quarters. The position peaked at $51.6M in Q4 2021. 116 funds tracked by Wall St. Rank hold MXCT as of Q2 2023.

  • BAMCO Inc reported no remaining MaxCyte position as of Q2 2023 after selling out during the quarter.
  • BAMCO Inc sold 1,987,904 MaxCyte shares in Q2 2023, an estimated $9.84M.
  • BAMCO Inc first reported a position in MaxCyte in Q3 2021 and held it in 7 quarters.
  • BAMCO Inc's MaxCyte position peaked at $51.6M in Q4 2021.
  • 116 funds tracked by Wall St. Rank held MaxCyte as of Q2 2023.

Based on BAMCO Inc's 13F filing for Q2 2023, filed 14 Aug 2023.